BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17273135)

  • 1. Proton pump inhibitors in general medicine. Comparison of routine practices with marketing authorization indications.
    Levy-Neumand O; Carniaux F; Bonaz B; Durand A; Roblin X
    Gastroenterol Clin Biol; 2007 Jan; 31(1):78-83. PubMed ID: 17273135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survey of the prescriptions of proton pump inhibitors in patients admitted in an internal medicine ward: how is the compliance to the French guidelines?].
    Sauvaget L; Rolland L; Dabadie S; Desblaches J; Bernard N; Vandenhende MA; Bonnet F; Pédeboscq S; Morlat P
    Rev Med Interne; 2015 Oct; 36(10):651-7. PubMed ID: 26051189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do recent reports about the adverse effects of proton pump inhibitors change providers' prescription practice?
    Al-Qaisi MT; Kahn A; Crowell MD; Burdick GE; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29873678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine].
    Marie I; Moutot A; Tharrasse A; Hellot MF; Robaday S; Hervé F; Lévesque H
    Rev Med Interne; 2007 Feb; 28(2):86-93. PubMed ID: 17092611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risks.
    Soubra L; Issa M
    Int J Pharm Pract; 2019 Aug; 27(4):386-392. PubMed ID: 30942513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the prescription of proton pump inhibitors in persons aged 75years and older in a geriatric acute-care unit].
    Dipanda M; Pioro L; Buttard M; d'Athis P; Asgassou S; Putot S; Deïdda M; Laborde C; Putot A; Manckoundia P
    Therapie; 2017 Dec; 72(6):669-675. PubMed ID: 28939010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].
    Daumas A; Garros E; Mendizabal H; Gayet S; Bernard F; Bagnères D; Demoux AL; Rossi P; Villani P; Granel B
    Rev Med Interne; 2018 Aug; 39(8):618-626. PubMed ID: 29628172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
    Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
    Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database.
    Bashford JN; Norwood J; Chapman SR
    BMJ; 1998 Aug; 317(7156):452-6. PubMed ID: 9703528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice patterns of reflux medication prescriptions in otolaryngology compared to other specialties.
    Luetzenberg FS; Jiang N
    Laryngoscope; 2020 Feb; 130(2):321-327. PubMed ID: 30861137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriateness of proton pump inhibitors prescription in patient admitted to hospital: An observational study.
    Gendre P; Mocquard J; Huon JF
    Ann Pharm Fr; 2023 Jun; 81(4):596-603. PubMed ID: 36375532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
    Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
    BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and dyspepsia: physicians' attitudes, clinical practice, and prescribing habits.
    O'Connor HJ
    Aliment Pharmacol Ther; 2002 Mar; 16(3):487-96. PubMed ID: 11876702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
    Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
    J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General practice variation when initiating long-term prescribing of proton pump inhibitors: a nationwide cohort study.
    Haastrup PF; Rasmussen S; Hansen JM; Christensen RD; Søndergaard J; Jarbøl DE
    BMC Fam Pract; 2016 May; 17():57. PubMed ID: 27233634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing of proton-pump inhibitors: auditing the management and reasons for prescribing in Danish general practice.
    Jarbøl DE; Lykkegaard J; Hansen JM; Munck A; Haastrup PF
    Fam Pract; 2019 Nov; 36(6):758-764. PubMed ID: 31165863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases.
    Goupil B; Balusson F; Naudet F; Esvan M; Bastian B; Chapron A; Frouard P
    BMJ; 2019 Nov; 367():l6015. PubMed ID: 31690553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors.
    Morse E; Fujiwara RJT; Mehra S
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):70-76. PubMed ID: 30325706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
    Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.